Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Research and Innovation Action · Running

STRONG-AYA The Strong-aya Initiative: Improving the Future of Young Adults with Cancer

Coordinator
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, Netherlands
Runs
1 October 2022 to 30 September 2027
Status
Running
EU funding
€7.2m
Total cost
€7.3m
Partners
15 organisations in 7 countries
Type
Research and Innovation Action
Grant agreement
101057482

What the project is doing

In the project's own words, from its summary on CORDIS.

STRONG-AYA is a new, interdisciplinary, multi-stakeholder European network to improve healthcare services, research and outcomes for Adolescents and Young Adults (AYA) with cancer, defined as individuals aged 15-39 years at cancer diagnosis. AYAs with cancer form a unique group; they face age-specific issues (e.g. infertility, unemployment, financial problems) and decreased quality of life due to cancer and its treatment.

Unlike dedicated healthcare and trials for pediatric cancer patients, AYA-specific healthcare services are scarce and vary across Europe. AYAs who are at the core of society and economy need access to age-adjusted and high-quality healthcare. AYA-care and research will benefit from collection and pooling of patient-centered data and collaboration among all stakeholders: patients, healthcare professionals, scientists, and policymakers.

Our consortium of clinical and scientific leaders in AYA-care, data science and registries, European Cancer Organisation, Youth Cancer Europe and EORTC will build on previous initiatives and EU grants. Within STRONG-AYA we will set up a value-based healthcare research ecosystem to develop data-driven, interactive policy and visualization tools that bring, in co-creation with all stakeholders including patients, novel insights into AYA healthcare.

The project objectives, include: 1) Development of a Core Outcome Set (COS) for AYAs with cancer; 2) Implementation of the COS in 5 national healthcare systems (FR, IT, NL, UK, PL) and establish national infrastructures for outcome data management and clinical decision-making and a pan-European ecosystem that also welcomes future European countries; 3) Disseminate outcomes and facilitate interactions between national and pan-European stakeholders to develop data-driven analysis tools to process and present relevant outcomes, establish feedback loops for AYA cancer patients and the healthcare systems, and improve the reporting and assessment of outputs towards policy-makers.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek ZiekenhuisAmsterdamNetherlandsCoordinator
European Cancer OrganisationBruxelles / BrusselBelgiumParticipant
Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer AisblBruxelles / BrusselBelgiumParticipant
Centre De Lutte Contre Le Cancer Leon BerardLyonFranceParticipant
Institut Gustave RoussyVillejuifFranceParticipant
Fondazione Irccs Istituto Nazionale Dei TumoriMilanItalyParticipant
Ffund BVAbcoudeNetherlandsParticipant
Stichting Integraal Kankercentrum NederlandUtrechtNetherlandsParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut BadawczyWarszawaPolandParticipant
Fundatia Youth Cancer EuropeCluj NapocaRomaniaParticipant
The Leeds Teaching Hospitals National Health Service TrustLeedsUnited KingdomAssociatedpartner
The University of ManchesterManchesterUnited KingdomAssociatedpartner
University of LeedsLeedsUnited KingdomAssociatedpartner
University of SouthamptonSouthamptonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI